Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Omada Health, Inc. (OMDA) Financial Statements

Omada Health, Inc. (OMDA) reported trailing twelve-month revenue of $309.8M (up 47.6% year on year) and net income of $4.3M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $17.1M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OMDAOmada Health, Inc.Follow OMDA — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue122.8169.8260.2309.8
Gross profit70.0102.9170.9211.2
Research & development33.735.940.749.2
Operating income-66.0-43.7-12.0-0.5
Pre-tax income-67.5-47.1-12.84.3
Income tax0.00.00.00.0
Net income-67.5-47.1-12.84.3
Diluted EPS ($)-9.52-6.11-0.350.06
Diluted shares (mn)7.17.736.6—

USD millions · SEC XBRL

Omada Health, Inc. — questions

What is Omada Health, Inc.'s revenue?
$309.8M over the twelve months to 2026-06-30, up 47.6% year on year, from its 10-Q and 10-K filings.
What is Omada Health, Inc.'s net income?
$4.3M over the twelve months to 2026-06-30.
What is Omada Health, Inc.'s free cash flow?
$17.1M over the twelve months to 2026-06-30.
What are Omada Health, Inc.'s diluted earnings per share?
$0.06 over the twelve months to 2026-06-30.

Every figure on this page comes from Omada Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.